COMMUNIQUÉS West-GlobeNewswire

Weifa ASA: Karo Pharma AB announces a recommended voluntary cash offer to acquire all shares in Weifa ASA

24/08/2017 - 08:00

Karo Pharma AB announces a recommended voluntary cash offer to acquire all shares in Weifa ASA · Cash offer at NOK 35 per Weifa share valuing the total share capital of Weifa at approximately NOK 1.28 billion on a fully [...]

Novartis appoints Bertrand Bodson as Chief Digital Officer

24/08/2017 - 07:15

New leader to drive the digital transformation Novartis has embarked upon Basel, August 24, 2017 - Novartis announced today that Bertrand Bodson, Chief Digital and Marketing Officer for Sainsbury's Argos, has been [...]

Novartis Kisqali® (ribociclib) receives EU approval as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor

24/08/2017 - 07:10

Media release (PDF) This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for [...]

argenx reports second quarter business update and half-year 2017 financial results

24/08/2017 - 07:00

Management to host conference call today at 3 p.m. CEST / 9 a.m. EDT August 24, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a [...]

Probiodrug AG to Publish First Half 2017 Results on 31 August 2017

24/08/2017 - 07:00

Probiodrug AG to Publish First Half 2017 Results on 31 August 2017 HALLE (SAALE), Germany, 24 August 2017 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to [...]

Targovax ASA: Second quarter and first half 2017 results

24/08/2017 - 07:00

Oslo, Norway, 24 August 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces its second quarter and first half 2017 results. A [...]

ABLYNX ANNOUNCES 2017 HALF YEAR RESULTS AND YEAR-TO-DATE BUSINESS UPDATE

24/08/2017 - 07:00

REGULATED INFORMATION Important progress in key programmes and a strategic collaboration with Sanofi Conference call and webcast today at 4pm CET/10am ET GHENT, Belgium, 24 August 2017 - Ablynx [Euronext Brussels: ABLX [...]

IBA SA : IBA ANNONCE SES RÉSULTATS DU PREMIER SEMESTRE 2017

24/08/2017 - 07:00

IBA ANNONCE SES RÉSULTATS DU PREMIER SEMESTRE 2017 Revenus du groupe en hausse de 4,5 %, à EUR 152 millions Carnet de commandes des équipements en croissance, à EUR 321 millions, et carnet de commandes des services en [...]

IBA SA : IBA Reports Half Year Results for 2017

24/08/2017 - 07:00

IBA Reports Half Year Results for 2017 Group revenues up 4.5% to EUR 152 million Growing backlog in equipment of EUR 321 million and services backlog of EUR 689 million, up 21% To read the full 2017 half year results [...]

Bone Therapeutics Business Update for First Quarter 2017

24/08/2017 - 07:00

Bone Therapeutics Notice of Half Year 2017 Results Results to be announced on 31 August 2017 Gosselies, Belgium, 24 August 2017, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy [...]

Bone Therapeutics SA : Publie son rapport d'activité du T1 2017

24/08/2017 - 07:00

Bone Therapeutics publiera ses résultats semestriels, le 31 août 2017 Gosselies, Belgique, le 24 août 2017, 7h00 CET - BONE THERAPEUTICS (Euronext Bruxelles et Paris: BOTHE), société de thérapie cellulaire osseuse qui [...]

EDAP TMS Reports Record Second Quarter and First Half 2017 Results

23/08/2017 - 22:01

EDAP-TMS Reports Record Second Quarter and First Half 2017 Results Revenue increased 13.7% to a record €9.3 million for the second quarter of 2017 compared to €8.2 million in 2016 HIFU revenue grew 25% when compared to [...]

Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress

23/08/2017 - 18:31

Oslo, Norway, 23 August 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target treatment-resistant solid tumors, today announces [...]

IBA SA : INFORMATIONS EN MATIERE DE TRANSPARENCE

23/08/2017 - 18:00

IBA - INFORMATIONS EN MATIERE DE TRANSPARENCE Titre II de la loi du 2 mai 2007 et Arrêté Royal du 14 février 2008 Louvain-la-Neuve, Belgique, 23 août 2017 - IBA (Ion Beam Applications SA), le premier fournisseur mondial [...]

IBA SA : DATA CONCERNING TRANSPARENCY

23/08/2017 - 18:00

IBA - DATA CONCERNING TRANSPARENCY Heading II of the law of May 2, 2007 and the Royal Decree of February 14, 2008 Louvain-la-Neuve, Belgium, August 23, 2017 - IBA (Ion Beam Applications SA), the world's leading provider [...]

Novavax' Preclinical Influenza Nanoparticle Study Published in Vaccine

23/08/2017 - 13:00

Novel vaccine candidate, NanoFlu(TM), outperforms market-leading Fluzone® High Dose based on antibody titers and neutralization of recent and historic influenza viruses in a preclinical study GAITHERSBURG, Md., Aug. 23 [...]

Alligator Bioscience AB: Interim report January - June 2017

23/08/2017 - 13:00

Alligator Bioscience AB ( (Nasdaq Stockholm; ATORX ) Interim report January - June 2017 "We have advanced our project pipeline significantly during the second quarter. The immuno-oncology antibody ATOR-1017 moved into [...]

Shire plc : Director/PDMR Shareholding

23/08/2017 - 13:00

Director/PDMR Shareholding August 23, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Crown Bioscience Names Dr. Leon Hall Vice President of Global Scientific Excellence

23/08/2017 - 12:29

SANTA CLARA, Calif., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company [...]